Decorte Future Industries
Techstars '20London, GB · 6 employees on LinkedIn · 8 known investors
Find your way into Decorte Future Industries
Sign up to see every warm intro you have to Decorte Future Industries
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Decorte Future Industries team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Decorte Future Industries develops machine learning systems that extract health data from sound using proprietary AI models. The company serves both veterinary clinics and human health markets through its SoNUS AI technology, deployed via smartphone microphones and custom devices.
Also known as Decorte Future Industries Ltd · DFI
Founders & leadership

Investors · 8
How we know: the company's own site · the Techstars portfolio · funding news · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · research · decorte.co.uk · Not right? Tell us
How we know: Black Mountain Ventues's portfolio page · Not right? Tell us
How we know: press coverage · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seedApr 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Sep 2026Decorte Future Industries (DFI) is a UK-based deep tech company that builds machine learning systems which extract health data from sound captured by standard microphones. Its core technology is the Sound-based Natural Understanding System (SoNUS), described by the company as the first commercial sound-to-health machine learning system, developed from 2023 onwards. The models are designed to screen for heart, breathing, brain and gut conditions, and earlier descriptions of the company's Sonus Engine cite real-time analysis of health metrics relevant to cardiovascular disease, respiratory problems, depression and anxiety.
The company's first commercially available product is Sonus Health, an app that allows ordinary smartphones to perform health and heart scans of animals, which the company positions as equivalent in standard to auscultation performed by specialists in clinic. Sonus Health launched in January 2026 with an initial focus on animal health and the veterinary sector, and the company states it is used in veterinary clinics internationally. Alongside the veterinary product, DFI pursues human health applications, reporting paid services delivered under NDA to, among others, one of the world's largest automotive manufacturers, and clinical trials and studies in the US, EU and India.
DFI's approach shifted over time from custom hardware to consumer devices: it built an exoskeleton-derived smart-shirt prototype (Mark I, 2020-2021) and a compact button-style device (Mark II, 2022) used primarily to build a proprietary end-to-end training database, before refocusing in 2024 on running its models on standard smartphone microphones.
Founding story
The company originated in work by Dr Roeland P-J E Decorte, who spent two years independently developing exoskeleton systems for human health monitoring in his spare room before incorporating Decorte Future Industries in August 2019 as its sole founder. The early exoskeleton work was endorsed by the UK Ministry of Defence, after which he redirected the technology in 2020 from defence toward accessible, large-scale health screening.
Business model
DFI develops proprietary sound-based AI models and delivers them to end users through software running on consumer hardware. The commercial entry point is the Sonus Health app for veterinary clinics, while on the human health side the company has performed paid, NDA-covered engagements for large corporate clients.
Revenue is generated from commercial deployment of the Sonus Health app in veterinary clinics and from paid human-health services contracted with large corporate clients under non-disclosure agreements; the company reports reaching first revenue in the 2025-2026 period.
Traction
Sonus Health launched in January 2026 and recorded more than 160 clinics signing up within days, with the company also citing a waiting list of over 160 clinics seeking access. The product performed its 3,000th scan by June 2026. The company reports clinical trials and studies in the US, EU and India, a partnership with one of the largest hospital chains in the world, and paid NDA-covered work for a major automotive manufacturer.
Latest developments
Sonus Health was launched in January 2026 and covered by Startups Magazine and trade publications; more than 160 clinics registered within days of launch, and the product completed its 3,000th scan in June 2026.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
The company positions sound-based health sensing as a means of democratising health screening across geographies and species, including for populations with limited access to traditional healthcare. It was ranked 7th most impactful AI startup in Europe in May 2024, placed 27th in the TechRound 100 in December 2023, and is described as a Young Business of the Year 2023 winner.
The company frames its differentiation as the ability to deliver in-clinic-grade auscultation and health analysis through hardware that is already ubiquitous — standard microphones and smartphones — rather than dedicated medical devices, supported by a proprietary sound-to-health training database built over several years.
Technology
DFI's SoNUS (Sound-based Natural Understanding System) machine learning engine extracts complex health data such as cardiovascular, respiratory, neurological and gastrointestinal metrics from audio captured by standard microphones, operating in real time on ordinary smartphones. The models were trained on a proprietary database built through the company's own hardware deployments, including a smart-shirt prototype (Mark I) and a button-style wearable (Mark II).
Go-to-market
Sonus Health was launched to veterinary clinics as a smartphone app, with the company reporting more than 160 clinics signing up within days of launch. Visibility is supported by extensive media commentary, conference keynotes and policy engagement by the founder, including appearances at the UK House of Lords, the Mayor of London's GROW Summit and London Tech Week, and the company also reports direct enterprise engagements on the human health side.
Veterinary clinics and pet owners are the initial commercial market via Sonus Health. Longer term the company targets consumer and human health screening at scale, as well as healthcare providers, hospital chains and large corporates, including populations in rural areas with limited access to healthcare.
Geography
The company describes itself as Cambridge, UK-based, and is registered in the UK. Its clinical validation activity spans the US, EU and India, and Sonus Health is reported as in use in veterinary clinics across the world.
History
Dr Roeland P-J E Decorte founded Decorte Future Industries in August 2019 as a solo founder, after two years of independently developing exoskeleton systems capable of monitoring human health, work that attracted and was endorsed by the UK Ministry of Defence. In 2020 the company moved away from defence applications towards large-scale public health monitoring and screening, and was selected for the Techstars London accelerator, which waived its policy against one-person companies. Between 2020 and 2022 DFI assembled a technical team by recruiting doctoral researchers from University of Cambridge sensor groups working on machine learning for sound-based health data, alongside software and ML engineers, and built the Mark I smart-shirt and Mark II button device prototypes. From 2023 it developed the SoNUS engine, pivoted in 2024 to smartphone-microphone deployment, restructured its organisation and strategy in early 2025 to accelerate commercialisation, and launched the Sonus Health brand and app roughly nine months later, reaching first revenue and growth in 2025-2026.
Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 10
launches, deals, and filingsDFI launched Sonus Health, its first commercially available product, enabling standard smartphones to perform health and heart scans of animals; launch covered in Startups Magazine and trade magazines.
In early 2025 DFI overhauled its structure and strategy to accelerate translation of its AI capabilities into commercially available products.
DFI moved away from custom devices to running its models on standard consumer smartphone microphones.
TechRound reported that Google and Microsoft were both actively working with Decorte, and that the company was partnered with some of the world's largest healthcare providers.
DFI was selected from thousands of applicants for Techstars' London accelerator in 2020, with Techstars waiving its policy against one-person companies; Techstars later made a follow-on investment through its venture arm.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structureCompanies House · registry record
View on Companies House ↗- Registered name
- DECORTE FUTURE INDUSTRIES LTD
- Company number
- 12176817
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 28 Aug 2019
- Registered office
- Sas House Friarswood, Chipperfield Road, Kings Langley, Hertfordshire, WD4 9JB
- Nature of business (SIC)
- 62012 — Business and domestic software development63990 — Other information service activities n.e.c.71129 — Other engineering activities72190 — Other research and experimental development on natural sciences and engineering
- Accounts
- last made up to 31 Aug 2025 · next due 31 May 2027
- Confirmation statement
- last made up to 27 Aug 2025 · next due 10 Sept 2026
Current officers · 1
- Roeland Pieter-Jan Ewoud Decorte — director, appointed 28 Aug 2019
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.
▸Research sources · 6
primary sources listed
- Decorte Future Industriesdecortefutureindustries.com · web
6 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Decorte Future Industries do?
- UK deep tech company using machine learning to extract cardiovascular, respiratory, neurological and gut health data from sound.
- Who founded Decorte Future Industries?
- Decorte Future Industries was founded by Dr Roeland P-J E Decorte.
- Who are Decorte Future Industries's investors?
- Decorte Future Industries's investors include Techstars, Black Mountain Ventues, Techstars London 2016.
- Where is Decorte Future Industries headquartered?
- Decorte Future Industries is headquartered in London, GB.

